Most people recover from the infection, but it poses great risks for those who don’t. A new drug may cure 1 in 5 of these patients.
Source: https://www.nytimes.com/2026/05/28/health/hepatitis-b-chronic-bepirovirsen.html
About the Author
stocks news and daily news
